- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '81235'
    - '81240'
    - '81245'
  conditions:
    any_of:
    - dx_in_value_set: vs_egfr_mutation_testing_2025_09
    - dx_in_value_set: vs_lung_cancer_molecular_2025_09
    - dx_in_value_set: vs_targeted_therapy_selection_2025_09
    all_of:
    - min_age: 18
    - max_age: 85
    - prior_service_required:
        cpt: ['88305', '88307']
        lookback_days: 90
        description: "Tissue biopsy confirming adenocarcinoma of lung"
  logic:
    outcome: PA_REQUIRED
    notes: EGFR mutation testing for lung adenocarcinoma targeted therapy selection
  precedence: 90
  effective_start: '2025-01-01'
  place_of_service:
    include: ['11', '21', '22', '81']
  _meta:
    source: "UnitedHealth 2025.09 Laboratory Testing Guidelines"
    last_verified: "2025-09-14T18:03:39-07:00"

- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '81275'
    - '81276'
  conditions:
    any_of:
    - dx_in_value_set: vs_kras_mutation_testing_2025_09
    - dx_in_value_set: vs_colorectal_cancer_molecular_2025_09
    - dx_in_value_set: vs_anti_egfr_therapy_2025_09
    all_of:
    - min_age: 18
    - max_age: 85
    - prior_service_required:
        cpt: ['88305', '88307']
        lookback_days: 90
        description: "Tissue biopsy confirming colorectal adenocarcinoma"
  logic:
    outcome: PA_REQUIRED
    notes: KRAS mutation testing for colorectal cancer anti-EGFR therapy selection
  precedence: 90
  effective_start: '2025-01-01'
  place_of_service:
    include: ['11', '21', '22', '81']
  _meta:
    source: "UnitedHealth 2025.09 Laboratory Testing Guidelines"
    last_verified: "2025-09-14T18:03:39-07:00"

- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '81445'
    - '81455'
  conditions:
    any_of:
    - dx_in_value_set: vs_comprehensive_genomic_profiling_2025_09
    - dx_in_value_set: vs_tumor_sequencing_2025_09
    - dx_in_value_set: vs_precision_oncology_2025_09
    all_of:
    - min_age: 18
    - max_age: 85
    - prior_service_required:
        cpt: ['88305', '88307']
        lookback_days: 90
        description: "Advanced stage solid tumor with adequate tissue for testing"
  logic:
    outcome: PA_REQUIRED
    notes: Comprehensive genomic profiling for advanced solid tumors when targeted therapy options exist
  precedence: 95
  effective_start: '2025-01-01'
  place_of_service:
    include: ['11', '21', '22', '81']
  _meta:
    source: "UnitedHealth 2025.09 Laboratory Testing Guidelines"
    last_verified: "2025-09-14T18:03:39-07:00"

- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '81479'
  conditions:
    any_of:
    - dx_in_value_set: vs_unlisted_molecular_pathology_2025_09
    - dx_in_value_set: vs_rare_mutation_testing_2025_09
    - dx_in_value_set: vs_novel_biomarker_2025_09
    all_of:
    - min_age: 18
    - max_age: 85
    - prior_service_required:
        cpt: ['88305', '88307']
        lookback_days: 90
        description: "Malignancy with clinical indication for novel biomarker testing"
  logic:
    outcome: PA_REQUIRED
    notes: Unlisted molecular pathology testing for rare mutations or novel biomarkers
  precedence: 85
  effective_start: '2025-01-01'
  place_of_service:
    include: ['11', '21', '22', '81']
  _meta:
    source: "UnitedHealth 2025.09 Laboratory Testing Guidelines"
    last_verified: "2025-09-14T18:03:39-07:00"
